S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 12.39 CNY 5.27% Market Closed
Market Cap: 18.2B CNY

Wall Street
Price Targets

Price Targets Summary
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Wall Street analysts forecast Shenzhen Hepalink Pharmaceutical Group Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.

Lowest
Price Target
7.47 CNY
40% Downside
Average
Price Target
7.55 CNY
39% Downside
Highest
Price Target
7.77 CNY
37% Downside
Shenzhen Hepalink Pharmaceutical Group Co Ltd Competitors:
Price Targets
DMP
Dermapharm Holding SE
37% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
22% Upside
PAHC
Phibro Animal Health Corp
18% Downside
000513
Livzon Pharmaceutical Group Inc
2% Upside
1558
YiChang HEC ChangJiang Pharmaceutical Co Ltd
2% Upside
NEU
Neuren Pharmaceuticals Ltd
88% Upside
300725
PharmaBlock Sciences Nanjing Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Shenzhen Hepalink Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 7%.

11%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shenzhen Hepalink Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 20%.

9%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Shenzhen Hepalink Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 14%.

6%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's stock price target?
Price Target
7.55 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 20%.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 14%.

Back to Top